Evidence map›Paper›PMID 38766192›Full record

ArticleResearch square2024

Tumor microenvironmental determinants of high-risk DCIS progression.

Alexander Borowsky, Alexa Glencer, Kirithiga Ramalingam, Nicole Schindler, Hidetoshi Mori, Parchi Ghule, Kyra Lee, Daniela Nachmanson, Adam Officer, Olivier Harismendy and 8 more

Abstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Alexander BorowskyUC Davis.ORCID 0000-0003-3117-9202
Alexa GlencerUCSF.
Kirithiga RamalingamUCSF.ORCID 0000-0002-1774-6891
Nicole SchindlerUCSF.
Hidetoshi MoriUniversity of California Davis.
Parchi GhuleUniv Vermont Medical School.
Kyra LeeU Vermot.
Daniela NachmansonUCSD.
Adam OfficerUCSD.
Olivier HarismendyUCSD.
Janet SteinUniversity of Vermont College of Medicine.ORCID 0000-0002-2474-6822
Gary SteinUniversity of Vermont Medical School.
Mark EvansU Vermont.
Donald WeaverU Vermont.
Christina YauUCSF.
Gillian HirstUniversity of California, San Francisco.ORCID 0000-0002-4502-0035
Michael CampbellUniversity of California San Francisco.ORCID 0000-0002-3788-9240
Laura EssermanUCSF.

Funding

Elucidating the molecular and contextual basis for IDLE ultralow risk lesions and the tumor immune microenvironment of high risk in situ and invasive breast cancersU01CA196406 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOROWSKY, ALEXANDER D, ESSERMAN, LAURA J · 2015 to 2020
$5.8M
Vermont Breast Cancer Molecular Characterization LaboratoryU01CA196383 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SPRAGUE, BRIAN L, STEIN, JANET L · 2015 to 2020
$5.4M
Surgical Oncology Training GrantT32CA251070 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ESSERMAN, LAURA J · 2020 to 2024
$1.5M
NCI NIH HHS T32 CA251070NCI NIH HHS U01 CA196383NCI NIH HHS U01 CA196406
6 · The paper itself

Abstract

Ductal carcinoma

Identifiers

PMID38766192
PMCPMC11100907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.